000 01270 a2200373 4500
005 20250512065122.0
264 0 _c19880220
008 198802s 0 0 eng d
022 _a0017-8748
024 7 _a10.1111/j.1526-4610.1987.hed2709503.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoccuni, M
245 0 0 _aPentazocine in migraine: subjective and pupillary abnormal effects.
_h[electronic resource]
260 _bHeadache
_cOct 1987
300 _a503-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBody Image
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMigraine Disorders
_xphysiopathology
650 0 4 _aNaloxone
_xpharmacology
650 0 4 _aPentazocine
_xadverse effects
650 0 4 _aPerceptual Disorders
_xchemically induced
650 0 4 _aPupil
_xdrug effects
650 0 4 _aVisual Perception
_xdrug effects
700 1 _aCangi, F
700 1 _aFusco, B M
700 1 _aCurradi, C
700 1 _aSicuteri, F
773 0 _tHeadache
_gvol. 27
_gno. 9
_gp. 503-8
856 4 0 _uhttps://doi.org/10.1111/j.1526-4610.1987.hed2709503.x
_zAvailable from publisher's website
999 _c3698533
_d3698533